Herb-Drug
Interaction Testing
(HDI)
Evaluation of potential interaction risks between herbal products, supplements and medications.
Advancing Drug Interaction Testing with
Strengthening our capability in herb-drug, drug-drug interaction assessment and bioanalytical research for a safer, healthier tomorrow.
We are proud to announce the successful installation of our new LC-MS/MS Triple Quadruple (QQQ) system.
This advanced platform enables highly sensitive and selective quantification of drugs, metabolites and bioactive compounds, empowering us to deliver reliable scientific data that supports product safety, regulatory compliance and innovation across multiple industries.
Evaluation of potential interaction risks between herbal products, supplements and medications.
Evaluation of potential interaction risks between medications during drug development.
Authentication of raw materials used during the manufacturing of products
Sensitive quantification of compounds, metabolites and biomarkers in samples
* In development stage
Many natural products, supplements and active ingredients contain bioactive compounds that may influence drug metabolism. With this new LC-MS/MS QQ capability, MyGenome can support industry partners with reliable data to improve safety, regulatory readiness and consumer confidence.
MyGenome welcomes collaboration with researchers, manufacturers, healthcare innovators and regulatory stakeholders seeking advanced analytical support for drug interaction and safety studies.
Let’s talk about how we can support your research and development needs.
03-2161 6113
info@mygenome.asia
www.mygenome.asia